Hypoglycemic effects and the use of kelp in diabetes mellitus (DM) model rats induced by alloxan were investigated. Sixty healthy male rats were used to establish DM models by injecting alloxan intraperitoneally. Kelp powder was added to the general forage for the rats. The levels of fasting blood glucose (FBG) were determined by an automatic blood glucose device. Electrochemiluminescence immunoassay was applied to determine the serum levels of insulin. The serum levels of malondialdehyde (MDA) were measured by thiobarbituric acid assay and nitric oxide (NO) by nitrate reductase assay. The activities of superoxide dismutase (SOD) were determined by xanthinoxidase assay and glutathione peroxidase (GSH-Px) by chemical colorimetry. The shape and structure of islet cells were observed with Hematine-Eosin staining, and the expression of superoxide dismutase (SOD) and inducible nitric oxide synthase (iNOS) in islet cells were detected by immunohistochemical assay. The results showed that the serum levels of insulin after treatment with kelp powder increased significantly compared to those in the DM-model group, while the FBG in the medium-high dose treated groups decreased significantly compared to those in the DM-model group ( P < 0.05). The levels of MDA and NO in the kelp powder groups were lower than those in the DM-model group, while the activities of SOD and GSH-Px were higher than those in the DM-model group, of which a significant difference existed between the medium-high dose treated groups and the DM-model group ( P < 0.05). The shape and structure of islet cells improved with the up-expressing SOD and down-expressing iNOS in the medium-high dose treated groups compared to those in the DM-model group ( P < 0.05). There were no significant differences between the medium and high dose treated groups, all above indexes ( P > 0.05). It is suggested that kelp might aid recovery of the the islet cell secreting function and reduce the level of FBG by an antioxidant effect.
References
[1]
Shih, C.C.; Wu, Y.W.; Lin, W.C. Anti-hyperglycaemic and anti-oxidant properties of anoectochilus formosanus in diabetic rats. Clin. Exp. pharmacol. Physiol 2002, 29, 684–688.
[2]
Surapaneni, K.M.; Venkataramana, G. Status of lipid peroxidation, glutathione, ascorbic acid, vitamin E and antioxidant enzymes in patients with osteoarthritis. Indian J. Med. Sci 2007, 61, 9–14.
[3]
Bian, K.; Ke, Y.; Kamisaki, Y.; Murad, F. Proteomic modification by nitric oxide. Pharmacol. Sci 2006, 101, 271–279.
[4]
Challa, S.R.; Akula, A.; Metla, S.; Gopal, P.N. Partial role of nitric oxide in infarct size limiting effect of quercetin and rutin against ischemia-reperfusion injury in normal and diabetic rats. Indian J. Exp. Biol 2011, 49, 207–210.
[5]
Aguilar, A.; Alvarez-Vijande, R.; Capdevila, S.; Alcoberro, J; Alcaraz, A. Antioxidant patterns (superoxide dismutase, glutathione reductase and glutathione peroxidase) in kidneys from non-heart-beating-donors: Experimental study. Transpl. Proc 2007, 39, 249–252.
[6]
Chung, S.S.; Kim, M.; Youn, B.S.; Lee, N.S.; Park, J.W.; Lee, I.K.; Lee, Y.S.; Kim, J.B.; Cho, Y.M.; Lee, H.K.; et al. Glutathione peroxidase mediates the antioxidant effect of peroxisome proliferator-activated receptor in human skeletal muscle cells. Mol. Cell Biol 2009, 29, 20–30.
[7]
Tseng, CK. Algal biotechnology industries and research activities in China. J. Appl. Phycol 2001, 13, 375–380.
[8]
Huang, L.; Guo, H.W.; Huang, Y.; Xue, K. The association of Lipoprotein lipase gene polymorphism with hyperlipidemia and dietary predisposition of obesity. Acta Nutr. Sin 2007, 29, 228–231.
[9]
Chinese Pharmcopoeia Commission. Chinese Pharmacopoeia, Part I, 2000 ed.; Chemical Industry Press: Beijing, China, 2000; pp. 168–170.
[10]
Zhu, L.; Zhang, Q.; Wang, Y.F.; Kang, Y.Y.; Cen, Y.Z. Determination of polysaccharide from Ecklonia kurome. Chin. J. Mar. Drugs 2005, 24, 47–48.
[11]
Zhou, Q.F.; Li, M.Y.; Na, G.S.; Li, C.W. Progress in research of anti-tumor mechanisms of marine polysaccharides. Chin. Pharmacol. Bull 2009, 25, 995–997.
[12]
Xu, X.Y.; Shuai, L.; Guo, Y.L.; Duan, D.L. Regulating effects and mechanism of Laminaria Japonica on serum lipid of hyperlipidemia in rats. Chin. J. Mar. Drugs 2009, 28, 1–4.
[13]
Shuai, L.; Xu, X.Y.; Guo, Y.L.; Duan, D.L. Study on the antioxidant effects of Laminaria japonica in hyperlipemia rats. Chin. J. Mar. Drugs 2010, 29, 1–4.
[14]
Wang, T.X.; Wang, T.X.; Pang, J.H. Study on the hypoglycemic and hypolipidemic effect of Laminarina japonica polysaccharides. Acta Nutr. Sin 2007, 29, 99–100.
[15]
Ceriello, A.; Motz, E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol 2004, 24, 816–823.
[16]
Capellini, V.K.; Baldo, C.F.; Celotto, A.C.; Batalh？o, M.E.; Cárnio, E.C.; Rodrigues, A.J.; Evora, P.R. Oxidative stress is not associated with vascular dysfunction in a model of alloxan-induced diabetic rats. Arq. Bras. Endocrinol. Metabol 2010, 54, 530–539.
[17]
Van Guilder, H.D.; Bixler, G.V.; Kutzler, L.; Brucklacher, R.M.; Bronson, S.K.; Kimball, S.R.; Freeman, W.M. Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathy. PLoS One 2011, 6, doi:10.1371/journal.pone.0016271.
[18]
Mircescu, G. Oxidative stress: An accomplice to uremic toxicity? Ren Nutr 2006, 16, 194–198.
[19]
Lushchak, V.I. Free radical oxidation of proteins and its relationship with functional state of organisms. Biol. Chem. (Mosc.) 2007, 72, 809–827.
[20]
Zhou, T.; Zhou, K.K.; Lee, K.; Gao, G.; Lyons, T.J.; Kowluru, R.; Ma, J.-X. The role of lipid peroxidation products and oxidative stress in activation of the canonical wingless-type MMTV integration site (WNT) pathway in a rat model of diabetic retinopathy. Diabetologia 2011, 54, 459–468.
[21]
Chaiyasut, C.; Kusirisin, W.; Lailerd, N.; Lerttrakarnnon, P.; Suttajit, M.; Srichairatanakool, S. Effects of phenolic compounds of fermented thai indigenous plants on oxidative stress in streptozotocin-induced diabetic rats. Evid. Based Complement. Altern 2011, 2011, 74–77.
[22]
Kr？ncke, K.D.; Fehsel, K.; Suschek, C.; Kolb-Bachofen, V. Inducible nitric oxide synthesis-derived nitric oxide in gene regulation, cell death and cell survival. Int. Immunopharmacol 2001, 1, 1407–1420.
[23]
Chapman, J.; Miles, P.D.; Ofrecio, J.M.; Neels, J.G.; Yu, J.G.; Resnik, J.L.; Wilkes, J.; Talukdar, S.; Thapar, D.; Johnson, K.; et al. Osteopontin is required for the early onset of high fat diet-induced insulin resistance in mice. PLoS One 2010, 5, doi:10.1371/journal.pone.0013959.
[24]
Soto, C.; Pérez, J.; García, V.; Uría, E.; Vadillo, M.; Raya, L. Effect of silymarin on kidneys of rats suffering from alloxan-induced diabetes mellitus. Phytomedicine 2010, 17, 1090–1094.
[25]
Silva, K.C.; Rosales, M.A.; Biswas, S.K.; Lopes de Faria, J.B.; Lopes de Faria, J.M. Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes. Diabetes 2009, 58, 1382–1390.
[26]
Ouslimani, N.; Peynet, J.; Bonnefont-Rousselot, D.; Thérond, P.; Legrand, A.; Beaudeux, J.L. Metfrom in decreases intracellular production of reactive oxygen species aortic endothelial cells. Metabolism 2005, 54, 829–834.
[27]
Bottino, R.; Balamurugan, A.N.; Tse, H.; Thirunavukkarasu, C.; Ge, X.; Profozich, J.; Milton, M.; Ziegenfuss, A.; Trucco, M.; Piganelli, J.D. Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 2004, 53, 2559–2568.
[28]
Liu, L.P.; Huang, J.; Chen, B.L.; Wang, J.; Li, M. Research on the hypoglycemic effect of marine alga Porphyridium cruentum in experimental diabetic mice. Chin. J. Mar. Drugs 2005, 24, 18–20.
[29]
Owu, D.U.; Antai, A.B.; Udofia, K.H.; Obembe, A.O.; Obasi, K.O.; Eteng, M.U. Vitamin C improves basal metabolic rate and lipid profile in alloxan-induced diabetes mellitus in rats. J. Biosci 2006, 31, 575–579.
